If you're shopping for a growth stock to power your portfolio down the road, it's important to choose players that -- even if they're not at the top today -- could become tomorrow's stars. They may be recovering right now or building a platform to bring in billions of dollars in revenue in the years to come. As an investor, you'll want to focus on the particular company's plans for the future and determine if that company has what it takes to reach its goals.

Two candidates with loads of potential are (NASDAQ: MRNA) and Teladoc Health (NYSE: TDOC). Their shares are suffering today, but I see this as a buying opportunity for two stocks that could be unstoppable in the coming years. Let's take a closer look at these two growth players to buy in 2023 and beyond.

Moderna's earnings soared over the past two years thanks to its blockbuster COVID-19 vaccine. And in earlier pandemic days, the stock climbed, too, on optimism about the vaccine, the company's first product. But in recent times, investors have worried about Moderna's post-pandemic days, and as a result, the stock has slipped.

Continue reading

Source Fool.com